Risk of death following application of paclitaxel‐coated balloons and stents in the femoropopliteal artery of the leg: a systematic review and meta‐analysis of …
Background Several randomized controlled trials (RCT s) have already shown that
paclitaxel‐coated balloons and stents significantly reduce the rates of vessel restenosis and …
paclitaxel‐coated balloons and stents significantly reduce the rates of vessel restenosis and …
An update on methods for revascularization and expansion of the TASC lesion classification to include below-the-knee arteries: a supplement to the Inter-Society …
TASC Steering Committee*, MR Jaff… - Journal of …, 2015 - journals.sagepub.com
The Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC)
guidelines were last updated in 2007 (TASC II) and represented the collaboration of …
guidelines were last updated in 2007 (TASC II) and represented the collaboration of …
[HTML][HTML] Trial of a paclitaxel-coated balloon for femoropopliteal artery disease
Background The treatment of peripheral artery disease with percutaneous transluminal
angioplasty is limited by the occurrence of vessel recoil and restenosis. Drug-coated …
angioplasty is limited by the occurrence of vessel recoil and restenosis. Drug-coated …
Durable clinical effectiveness with paclitaxel-eluting stents in the femoropopliteal artery: 5-year results of the Zilver PTX randomized trial
Background—This randomized controlled trial evaluated clinical durability of Zilver PTX, a
paclitaxel-coated drug-eluting stent (DES), for femoropopliteal artery lesions. Outcomes …
paclitaxel-coated drug-eluting stent (DES), for femoropopliteal artery lesions. Outcomes …
[HTML][HTML] Reporting standards of the Society for Vascular Surgery for endovascular treatment of chronic lower extremity peripheral artery disease
MC Stoner, KD Calligaro, RA Chaer, AM Dietzek… - Journal of vascular …, 2016 - Elsevier
Peripheral arterial disease (PAD) represents a spectrum from asymptomatic stenosis to limb-
threatening ischemia. The last decade has seen a tremendous increase in the variety of …
threatening ischemia. The last decade has seen a tremendous increase in the variety of …
[HTML][HTML] Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and …
Peripheral arterial disease (PAD) continues to grow in global prevalence and consumes an
increasing amount of resources in the United States health care system. Overall rates of …
increasing amount of resources in the United States health care system. Overall rates of …
Endovascular intervention for peripheral artery disease
AK Thukkani, S Kinlay - Circulation research, 2015 - Am Heart Assoc
Advances in endovascular therapies during the past decade have broadened the options for
treating peripheral vascular disease percutaneously. Endovascular treatment offers a lower …
treating peripheral vascular disease percutaneously. Endovascular treatment offers a lower …
Treatment effect of drug-coated balloons is durable to 3 years in the femoropopliteal arteries: long-term results of the IN. PACT SFA randomized trial
PA Schneider, JR Laird, G Tepe… - Circulation …, 2018 - Am Heart Assoc
Background—Randomized controlled trials have reported favorable 1-year outcomes with
drug-coated balloons (DCBs) for the treatment of symptomatic peripheral arterial disease …
drug-coated balloons (DCBs) for the treatment of symptomatic peripheral arterial disease …
Durability of treatment effect using a drug-coated balloon for femoropopliteal lesions: 24-month results of IN. PACT SFA
JR Laird, PA Schneider, G Tepe, M Brodmann… - Journal of the American …, 2015 - jacc.org
Background: Evidence from large, randomized, controlled peripheral artery disease trials
reporting long-term outcomes using drug-coated balloons (DCBs) is limited. Previously, the …
reporting long-term outcomes using drug-coated balloons (DCBs) is limited. Previously, the …
Peripheral artery disease: evolving role of exercise, medical therapy, and endovascular options
JW Olin, CJ White, EJ Armstrong… - Journal of the American …, 2016 - jacc.org
The prevalence of peripheral artery disease (PAD) continues to increase worldwide. It is
important to identify patients with PAD because of the increased risk of myocardial infarction …
important to identify patients with PAD because of the increased risk of myocardial infarction …